Eluminex Biosciences
PrivateLast Round
Series B
Feb 27, 2023
Total Funding Raised
$90M
Company Overview
Eluminex Biosciences operates in Healthcare & Life Sciences and is based in Suzhou. Its latest recorded funding round was a Series B round in February 2023.
Eluminex Biosciences is a biotechnology company that develops and commercializes innovative ophthalmic therapeutic solutions, including protein therapeutics and recombinant human collagen-based products, to treat vision-threatening diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Eluminex Biosciences Comparables
Compare Eluminex Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| VivaVision Biotech | 84% | |
| Arctic Vision | 79% | |
| ActualEyes, Inc. | 79% |
For institutional investors. Book with your work email.
Eluminex Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Feb 27, 2023 | ||||
| Series A | Nov 27, 2020 |
For institutional investors. Book with your work email.
Eluminex Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Oriza Holdings | Series B |
| Bencao Capital | Series B |
| Cenova Capital | Series B |
| GL Ventures | Series B, Series A |
| Lilly Asia Ventures | Series B, Series A |
| Lilly Asia Ventures | Series B, Series A |
| Guangzhou Yuexiu Industrial Investment Fund Management | Series B |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 27, 2023
$40M round led by Cenova Capital
- Nov 27, 2020
$50M round led by GL Ventures and Lilly Asia Ventures.
For institutional investors. Book with your work email.
Eluminex Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Eluminex Biosciences's valuation, stock price, and market status.
Is Eluminex Biosciences a public or private company?
Eluminex Biosciences is a private company.
What is the current stock price of Eluminex Biosciences?
Eluminex Biosciences is a private company, so its shares have no public market price. Caplight tracks Eluminex Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Eluminex Biosciences worth (valuation)?
Valuation information for Eluminex Biosciences is not publicly available.
Can I buy Eluminex Biosciences stock?
Eluminex Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Eluminex Biosciences's last funding round?
Eluminex Biosciences's most recent funding round was Series B on February 27, 2023.
Who are the main investors in Eluminex Biosciences?
Key investors in Eluminex Biosciences include Cenova Capital, GL Ventures, Lilly Asia Ventures, Lilly Asia Ventures, Quan Capital.
Will Eluminex Biosciences IPO soon?
No public IPO plans have been announced for Eluminex Biosciences.
How can I track Eluminex Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in Eluminex Biosciences's shares on secondary markets.